u/DM-McMike — thesis ledger

Window	Theses	Resolved	Win rate	Avg return	Median return
1d	1	1	0%	-44.7%	-44.7%
3d	1	1	0%	-44.7%	-44.7%
1w	1	1	0%	-63.3%	-63.3%
1m	1	1	0%	-69.8%	-69.8%
3m	1	1	0%	-71.1%	-71.1%
6m	1	1	0%	-84.3%	-84.3%
1y	1	1	0%	-89.7%	-89.7%

Window

Theses

Resolved

Wins

Win rate

Avg return

Median return

-44.7%

-63.3%

-69.8%

-71.1%

-84.3%

-89.7%

Thesis history

$INTSr/pennystocksDDbullish

u/DM-McMike · 366d agono track record yet

“I'm all in”

INTS - Strong Buy 🚀

Intensity Therapeutics has published peer-reviewed clinical evidence showing their intratumoral cancer therapy achieved 18-month median survival versus 3 months with standard therapy and 83% disease control versus 50% with existing treatments in heavily pretreated patients across 20+ cancer types. The company has potential for acquisition by major pharma and represents a paradigm shift from systemic chemotherapy to localized treatment with minimal side effects.

At post $33.00Now $3.40-89.7% since postedas of Oct 30, 4:45 PM ET

1d-44.7%

3d-44.7%

1w-63.3%

1m-69.8%

3m-71.1%

6m-84.3%

1y-89.7%

original post →

End of results.